- Home
- GORO vs DYAI Comparison
GORO vs DYAI Comparison
Compare GORO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORO
- DYAI
- Stock Information
- Founded
- GORO 1998
- DYAI 1979
- Country
- GORO United States
- DYAI United States
- Employees
- GORO N/A
- DYAI N/A
- Industry
- GORO Precious Metals
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GORO Basic Materials
- DYAI Health Care
- Exchange
- GORO Nasdaq
- DYAI Nasdaq
- Market Cap
- GORO 53.3M
- DYAI 54.4M
- IPO Year
- GORO N/A
- DYAI 2004
- Fundamental
- Price
- GORO $0.49
- DYAI $1.38
- Analyst Decision
- GORO Strong Buy
- DYAI Strong Buy
- Analyst Count
- GORO 1
- DYAI 1
- Target Price
- GORO $1.25
- DYAI $6.00
- AVG Volume (30 Days)
- GORO 2.7M
- DYAI 59.9K
- Earning Date
- GORO 05-01-2025
- DYAI 03-26-2025
- Dividend Yield
- GORO N/A
- DYAI N/A
- EPS Growth
- GORO N/A
- DYAI N/A
- EPS
- GORO N/A
- DYAI N/A
- Revenue
- GORO $73,897,000.00
- DYAI $3,495,389.00
- Revenue This Year
- GORO N/A
- DYAI $51.30
- Revenue Next Year
- GORO $48.90
- DYAI $73.26
- P/E Ratio
- GORO N/A
- DYAI N/A
- Revenue Growth
- GORO N/A
- DYAI 20.58
- 52 Week Low
- GORO $0.12
- DYAI $0.93
- 52 Week High
- GORO $0.74
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- GORO 48.79
- DYAI 46.47
- Support Level
- GORO $0.45
- DYAI $1.29
- Resistance Level
- GORO $0.66
- DYAI $1.45
- Average True Range (ATR)
- GORO 0.06
- DYAI 0.10
- MACD
- GORO -0.01
- DYAI 0.00
- Stochastic Oscillator
- GORO 17.86
- DYAI 41.38
About GORO Gold Resource Corporation
Gold Resource Corp is a gold and silver producer, developer, and explorer with operations in Oaxaca, Mexico, and Nevada, USA. It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.